Pirfenidone for Diabetic Nephropathy

Pirfenidone is an oral antifibrotic agent that benefits diabetic nephropathy in animal models, but whether it is effective for human diabetic nephropathy is unknown. We conducted a randomized, double-blind, placebo-controlled study in 77 subjects with diabetic nephropathy who had elevated albuminuri...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Sharma, Kumar, Ix, Joachim H., Mathew, Anna V., Cho, Monique, Pflueger, Axel, Dunn, Stephen R., Francos, Barbara, Sharma, Shoba, Falkner, Bonita, McGowan, Tracy A., Donohue, Michael, RamachandraRao, Satish, Xu, Ronghui, Fervenza, Fernando C., Kopp, Jeffrey B.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2011
Teme:
Clinical Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3103734/
https://ncbi.nlm.nih.gov/pubmed/21511828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2010101049
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki